Skip to content

Evaluation of the Clinical Efficacy and Feasibility of Digital Foot Care Intervention Strategies With Different Intensities in the Prevention of Diabetic Foot Ulcers.

Clinical AI-powered Remote Engagement for Diabetic Foot Ulcer Prevention

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07185048
Enrollment
1512
Registered
2025-09-22
Start date
2025-10-31
Completion date
2028-09-30
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcers (DFUs)

Brief summary

For people with diabetes who are at risk of foot ulcers, this study compares three digital foot care strategies (with different levels of intensity) to see which one is more effective at preventing ulcers and easier to use.

Interventions

BEHAVIORALConventional Foot Care Control Group

Standard Foot Care with Regular Follow-up

BEHAVIORALDigital Foot Care (Low-Intensity)

On the basis of routine management, the digital intervention modules will be added

BEHAVIORALDigital Foot Care (Moderate-Intensity)

Further integration of AI image analysis for auxiliary judgment and remote physician response.

Sponsors

First Affiliated Hospital of Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 50 years but \< 80 years; 2. Assessed to meet the criteria for the high-risk population for diabetic foot as defined by the International Working Group on the Diabetic Foot (IWGDF) (risk level 3); 3. Capable of using a smartphone to take photos and operate apps, or able to do so after simple training; 4. Willing to participate in the study and sign an informed consent form.

Exclusion criteria

1. Currently has an open foot wound or an unresolved foot ulcer; 2. History of major lower limb amputation above the ankle joint; 3. Pregnancy or breastfeeding; 4. Currently suffering from poorly controlled malignant tumors; 5. Receiving glucocorticoid or immunosuppressive therapy; 6. Diagnosed with vascular occlusive vasculitis; 7. Presence of foot fracture; 8. Significant visual impairment affecting image acquisition or operation; 9. Other conditions deemed inappropriate for participation in this study by the research team.

Design outcomes

Primary

MeasureTime frame
Incidence of Diabetic Foot Ulcers18 months after intervention initiation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026